Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 242,380 | 226,219 | 180,793 | 162,169 | 139,924 |
| Operating Income | -242,380 | -226,219 | -180,793 | -162,169 | -139,924 |
| Other Income | 29,550 | 59,646 | 40,075 | 25,089 | 36,800 |
| Pre-tax Income | -212,830 | -166,573 | -140,718 | -137,080 | -103,124 |
| Net Income Continuous | -212,830 | -166,573 | -140,718 | -137,080 | -103,124 |
| Net Income | $-212,830 | $-166,573 | $-140,718 | $-137,080 | $-103,124 |
| EPS Basic Total Ops | -1.56 | -1.22 | -1.04 | -1.02 | -0.83 |
| EPS Basic Continuous Ops | -1.56 | -1.22 | -1.04 | -1.02 | -0.83 |
| EPS Diluted Total Ops | -1.56 | -1.22 | -1.04 | -1.02 | -0.83 |
| EPS Diluted Continuous Ops | -1.56 | -1.22 | -1.04 | -1.02 | -0.83 |
| EPS Diluted Before Non-Recurring Items | -1.56 | -1.22 | -1.04 | -1.02 | -0.83 |
| EBITDA(a) | $-239,447 | $-225,723 | $-180,832 | $-169,060 | $-141,536 |